| scholarly article | Q13442814 |
| P50 | author | Theresa A. Lusardi | Q43161290 |
| Detlev Boison | Q43161293 | ||
| David L. Kaplan | Q61761312 | ||
| P2093 | author name string | Tianfu Li | |
| Eleanor M Pritchard | |||
| Andrew Wilz | |||
| Cory Szybala | |||
| P2860 | cites work | Adenosine receptors as therapeutic targets | Q24632095 |
| Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy | Q28366761 | ||
| Functionalized silk-based biomaterials for bone formation. | Q31565805 | ||
| Silk coatings on PLGA and alginate microspheres for protein delivery | Q33288412 | ||
| Kindling: the first decade | Q33539958 | ||
| Emerging insights into the genesis of epilepsy | Q33678164 | ||
| The role and regulation of adenosine in the central nervous system | Q34205330 | ||
| Current status and future directions in the pharmacotherapy of epilepsy | Q34552599 | ||
| Cell and gene therapies in epilepsy--promising avenues or blind alleys? | Q34737233 | ||
| In vivo degradation of three-dimensional silk fibroin scaffolds | Q34781676 | ||
| Silk-based biomaterials | Q34992589 | ||
| The clinical potential of antiepileptic gene therapy | Q35925614 | ||
| Adenosine and brain function | Q36083482 | ||
| Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs | Q36094581 | ||
| Kinetic studies of rat liver adenosine kinase. Explanation of exchange reaction between adenosine and AMP | Q72050247 | ||
| Focal treatment for refractory epilepsy: hope for the future? | Q79739749 | ||
| Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. | Q36391066 | ||
| The adenosine kinase hypothesis of epileptogenesis | Q36515651 | ||
| Concise review: prospects of stem cell therapy for temporal lobe epilepsy. | Q36729233 | ||
| Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. | Q36788952 | ||
| Silk polymer-based adenosine release: therapeutic potential for epilepsy | Q36819103 | ||
| Cell therapy in models for temporal lobe epilepsy | Q36848783 | ||
| Pharmacotherapy of epilepsy: new armamentarium, new issues | Q36873342 | ||
| Adenosine dysfunction in astrogliosis: cause for seizure generation? | Q36923994 | ||
| Adenosine as a neuromodulator in neurological diseases | Q36974004 | ||
| The promise of gene therapy for the treatment of epilepsy | Q37021317 | ||
| Adenosine as a modulator of brain activity. | Q37095277 | ||
| Cell and gene therapies for refractory epilepsy. | Q37211817 | ||
| Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade | Q40722338 | ||
| Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice | Q41862804 | ||
| Silk fibroin as an organic polymer for controlled drug delivery | Q42038479 | ||
| Electrospun silk-BMP-2 scaffolds for bone tissue engineering | Q42038481 | ||
| Reactions of 1-N6-ethenoadenosine nucleotides with myosin subfragment 1 and acto-subfragment 1 of skeletal and smooth muscle. | Q42250275 | ||
| Adenosine and ATP link PCO2 to cortical excitability via pH. | Q42530690 | ||
| Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo | Q43051288 | ||
| Rat brain expresses serum calcium-decreasing factor (caldecrin). | Q43828997 | ||
| Seizure suppression by adenosine-releasing cells is independent of seizure frequency | Q44103780 | ||
| Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy | Q44489270 | ||
| Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats | Q44553318 | ||
| Focally injected adenosine prevents seizures in the rat. | Q45142338 | ||
| Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy | Q45284051 | ||
| Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts | Q45882674 | ||
| Silk microspheres for encapsulation and controlled release | Q46067219 | ||
| Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury | Q46668123 | ||
| Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. | Q48181919 | ||
| Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. | Q48380900 | ||
| Adenosine A1 receptors are crucial in keeping an epileptic focus localized | Q48512398 | ||
| Biomaterial coatings by stepwise deposition of silk fibroin. | Q51321790 | ||
| In vitro degradation of silk fibroin. | Q51561651 | ||
| Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. | Q51570184 | ||
| Mechanism of silk processing in insects and spiders. | Q51830989 | ||
| Enzymatic degradation behavior of porous silk fibroin sheets. | Q52600760 | ||
| Adenosine measurement by a rapid HPLC-fluorometric method: induced changes of adenosine content in regions of rat brain | Q71606735 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 126-135 | |
| P577 | publication date | 2009-05-19 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | Antiepileptic effects of silk-polymer based adenosine release in kindled rats | |
| P478 | volume | 219 |
| Q42020157 | A silk platform that enables electrophysiology and targeted drug delivery in brain astroglial cells |
| Q50662920 | A1 not A2A adenosine receptors play a role in cortical epileptic afterdischarges in immature rats. |
| Q34073789 | Adenosine dysfunction and adenosine kinase in epileptogenesis |
| Q36036212 | Adenosine dysfunction in epilepsy |
| Q34788009 | Adenosine kinase as a target for therapeutic antisense strategies in epilepsy |
| Q39553867 | Adenosine prevents kindled seizures--an effect as smooth as silk |
| Q48170667 | Adenosine release during seizures attenuates GABAA receptor-mediated depolarization |
| Q26785351 | Adenosine-associated delivery systems |
| Q36643060 | Adenosinergic signaling in epilepsy |
| Q34193177 | Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery. |
| Q57817412 | Bioenergetic Mechanisms of Seizure Control |
| Q35594944 | Candidate drug targets for prevention or modification of epilepsy |
| Q35956389 | Comorbidities in Neurology: Is adenosine the common link? |
| Q90295794 | Effect of Silk Fibroin on Neuroregeneration After Traumatic Brain Injury |
| Q30541877 | Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. |
| Q54981587 | Genome Editing in Neuroepithelial Stem Cells to Generate Human Neurons with High Adenosine-Releasing Capacity. |
| Q36912637 | Glial adenosine kinase--a neuropathological marker of the epileptic brain |
| Q64106725 | Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development |
| Q35072901 | Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy |
| Q43090447 | Homeostatic control of brain function - new approaches to understand epileptogenesis. |
| Q36438511 | Implantable, multifunctional, bioresorbable optics |
| Q34349134 | Incorporation of proteinase inhibitors into silk-based delivery devices for enhanced control of degradation and drug release |
| Q43161211 | Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats |
| Q35552360 | Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis? |
| Q34220322 | Materials fabrication from Bombyx mori silk fibroin |
| Q34154555 | Methylxanthines, seizures, and excitotoxicity. |
| Q34842250 | Modulators of nucleoside metabolism in the therapy of brain diseases. |
| Q37042980 | Neural responses to electrical stimulation on patterned silk films. |
| Q39126886 | Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy. |
| Q92114438 | Research progress on adenosine in central nervous system diseases |
| Q37978191 | Review physical and chemical aspects of stabilization of compounds in silk |
| Q46236063 | Silk Fibroin Based Porous Materials. |
| Q37859773 | Silk fibroin biomaterials for controlled release drug delivery |
| Q33846966 | Silk fibroin encapsulated powder reservoirs for sustained release of adenosine |
| Q38007146 | Silk materials--a road to sustainable high technology |
| Q37714025 | Silk-based delivery systems of bioactive molecules. |
| Q26752724 | The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine |
| Q34997511 | Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation |
| Q34606639 | Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice |
Search more.